CHIEF EXECUTIVE OFFICER
Thu, Feb 15, 2024
Feb 15
4,750 shares @ $0.00
Decreased holdings by -8.30%
Net across this filing: +1.70% (+12,384 shares)
91st largest trade (out of 185)
Option ExercisePositive 90D History
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: +1.7% (+12,384 shares)
64% win rate · +2.3% median edge vs SPY (14 trades, 90-day · small sample)
Price 18% above 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology